Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.60 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | FDPS | P14324 | 3/20 | 0.50 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GGH | Q92820 | 1/20 | 0.45 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.44 |
| ▸ | KDM4A | O75164 | 2/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.44 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.44 |
| ▸ | TET3 | O43151 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1169260 | 0.87 | FOLH1 (0.48) | FOLH1NAALAD2FDPSGRM3CYP1A2 | |
| SCHEMBL21611867 | 0.85 | FOLH1 (0.59) | FOLH1NAALAD2FDPSLMNATSHR | |
| SCHEMBL5011486 | 0.83 | FDPS (0.56) | FOLH1NAALAD2FDPSLMNATSHR | |
| SCHEMBL328880 | 0.81 | FDPS (0.57) | FOLH1FDPSLMNATSHR | |
| SCHEMBL8633245 | 0.79 | FOLH1 (0.60) | FOLH1NAALAD2GRM3CYP1A2GGH | |
| SCHEMBL6037144 | 0.77 | FOLH1 (0.58) | FOLH1NAALAD2GRM3CYP1A2GGH | |
| SCHEMBL9176133 | 0.77 | FDPS (0.54) | FOLH1FDPSLMNA | |
| SCHEMBL10785210 | 0.76 | FDPS (0.67) | FDPS | |
| SCHEMBL1191457 | 0.75 | FOLH1 (0.56) | FOLH1NAALAD2GRM3CYP1A2 | |
| SCHEMBL2201753 | 0.75 | FOLH1 (1.00) | FOLH1NAALAD2GRM3CYP1A2GGH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9694357-B1 | Multi-acid polymers and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2017-07-04 | — | — | US | claimed |
| US-20240390504-A1 | MULTIFUNCTIONAL CONJUGATES | E P O S IASIS RES AND DEVELOPMENT LIMITED (CY) | 2024-11-28 | — | — | US | disclosed |
| US-11969473-B2 | Multifunctional conjugates | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2024-04-30 | — | — | US | disclosed |
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2023-01-26 | — | — | US | disclosed |
| US-11400160-B2 | Multifunctional conjugates | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2022-08-02 | — | — | US | disclosed |
| US-10930961-B2 | Multi-acid polymers from multifunctional amino phosphonic acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2021-02-23 | — | — | US | disclosed |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2020-05-28 | — | — | US | disclosed |
| EP-3648797-A1 | MULTIFUNCTIONAL CONJUGATES | EPOS-Iasis Research and Development, Ltd (CY) | 2020-05-13 | — | — | EP | disclosed |
| US-10468701-B2 | Multi-acid polymers from multifunctional amino acids and sulfonyl halide precursors and methods of making the same | NISSAN NORTH AMERICA, INC. (US) | 2019-11-05 | — | — | US | disclosed |
| US-20190013538-A1 | Multi-Acid Polymers From Multifunctional Amino Acids and Sulfonyl Halide Precursors and Methods of Making the Same | NISSAN MOTOR CO., LTD. (JP) | 2019-01-10 | — | — | US | disclosed |
| WO-2008125422-A2 | USE OF METAL NANOPARTICLES FOR DIAGNOSING ALZHEIMER DISEASE | GUERBET (FR) | 2008-10-23 | — | — | WO | disclosed |
| WO-2007138381-A2 | PHOSPHONATED OXAZOLIDINONES AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS INC. (CA) | 2007-12-06 | — | — | WO | disclosed |
| US-20060239913-A1 | Peptide conjugate for magnetic resonance imaging | GUERBET (FR) | 2006-10-26 | — | — | US | disclosed |
| EP-1635878-A2 | PEPTIDE CONJUGATE FOR MAGNETIC RESONANCE IMAGING | GUERBET (FR) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004112840-A2 | PEPTIDE CONJUGATE FOR MAGNETIC RESONANCE IMAGING | GUERBET (FR) | 2004-12-29 | — | — | WO | disclosed |
| US-20040253181-A1 | Novel compositions magnetic particles covered with gem-bisphosphonate derivatives | GUERBET (FR) | 2004-12-16 | — | — | US | disclosed |
| US-6140518-A | Steroid bisphosphonates | THE UNIVERSITY OF LIVERPOOL (GB) | 2000-10-31 | — | — | US | disclosed |
| EP-0036162-A1 | Low-phosphate foam regulated detergent | Henkel Kommanditgesellschaft auf Aktien (DE) | 1981-09-23 | — | — | EP | disclosed |
| US-4120890-A | ANTIPLAQUE, ANTITARTAR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1978-10-17 | — | — | US | disclosed |
| US-4077997-A | SEQUESTERING AGENTS, BASIC CATALYST, SAPONIFICATION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DT) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11969473-B2 | Multifunctional conjugates | MKI67, ACP3, CD44 | FOLH1 225/4885NAALAD2 915/4885FDPS 489/4885 |
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | FOLH1 225/4885NAALAD2 915/4885FDPS 489/4885 |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | FOLH1 215/4885NAALAD2 895/4885FDPS 467/4885 |
| US-20060239913-A1 | Peptide conjugate for magnetic resonance imaging | MMP11, MMP26, MMP3 | FOLH1 87/4885NAALAD2 86/4885FDPS 4083/4885 |
| US-20240390504-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | FOLH1 225/4885NAALAD2 915/4885FDPS 489/4885 |
| US-11400160-B2 | Multifunctional conjugates | MKI67, ACP3, CD44 | FOLH1 215/4885NAALAD2 895/4885FDPS 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.